Eung Yeop Kim1, Yoon Ho Nam2, Young Noh3, Young Hee Sung3, Byeong Ho Goh1, Joon Hyung Ann1, and Jongho Lee4
1Radiology, Gachon University Gil Medical Center, Incheon, Korea, Republic of, 2Radiology, Seoul St. Mary Hospital, Seoul, Korea, Republic of, 3Neurology, Gachon University Gil Medical Center, Incheon, Korea, Republic of, 4Electrical and Computer Engineering, Seoul National University, Seoul, Korea, Republic of
Synopsis
Susceptibility map-weighted
imaging (SMWI) improves both CNR and SNR in comparison with conventional SWI. In
this work, we compared SMWI with MEDIC (a multi-echo GRE imaging that combines
magnitude images via sum of squares) for nigrosome 1 imaging at 3T in terms of
interobserver agreement and diagnostic performance in 74 subjects (44 with
Parkinson’s disease). Two
experienced and two less-experienced reviewers visually assessed both imaging
sets separately. Compared with MEDIC, SMWI showed higher kappa values and larger
AUCs, regardless of level of experience. As a result, nigrosome 1 imaging using SMWI significantly improved diagnostic
performance as well as interobserver agreement.Purpose
Susceptibility map-weighted
imaging (SMWI) is a recently proposed magnetic susceptibility imaging method
that utilizes a quantitative susceptibility map (instead of a phase image) as the mask for susceptibility weighting. This new approach improves
both CNR and SNR in comparison with conventional SWI.
1 We
hypothesized that nigrosome imaging using SMWI has higher interobserver
agreement as well as higher diagnostic performance than that of MEDIC. The aim
of this study was to compare SMWI and MEDIC for nigrosome 1 imaging.
Methods
A
total 74 subjects (median age, 71 [IQR, 65-75]; 30 males; PD [n=44], DIP [n=13], healthy subjects [n=10],
NPH [n=2], essential tremor [n=1], MSA-C [n=1], MSA-P [n=1], PSP [n=1], and
vascular parkinsonism [n=1]) underwent 3T MRI using a 32-channel head coil. Oblique
axial 3D MEDIC imaging was obtained vertical to the longitudinal axis of the
midbrain. The scan parameters for MEDIC were as follows: TR, 88 ms; minimum TE,
11.1 ms; maximum TE, 66.9 ms (the number of echoes, 6; echo spacing, 11.1 ms); FA,
10°; ETL, 6; thickness, 1 mm; number of slices, 28; matrix, 384×384; FOV,
192×192; reduction factor of parallel imaging, 2. From the
multi-echo k-space data of MEDIC, QSM was caculated
using iLSQR,
2 and then SMWI was generated by using the
QSM images as a weighting mask (threshold value, 1 ppm; number of
multiplications, 4).
1
Details of the SMWI processing for the nigrosome 1 imaging are described in a separate abstract.
Four independent raters (two
experienced [a neuroradiologist and a neurologist; R1 and R2] and two less
experienced [third- and fourth year radiology residents] reviewers; R3 and R4)
classified the bilateral nigrosome 1 as ‘normal’ (iso- or hyperintensity in the central
portion of the presumed nigrosome 1 area), ‘possibly abnormal’ (hypointensity
in less than 50% of the presumed nigrosome 1 area and ‘definitely abnormal’
(hypointensity in equal to or more than 50% of the presumed nigrosome 1.
5,6 Each side was rated separately separately on both MEDIC and SMWI. For a simplified statistical analysis, the
subjects were re-classified as abnormal if any abnormality was determined on
either side of the nigrosome 1 area; a subject was classified as normal when
both nigrosome 1 regions were determined as normal. As both PD and MSA-P showed
abnormality in nigrosome 1, they were considered as an abnormal group. The
other subjects were categorized as a normal
group. The generalized kappa test was used to test if there is any improvement
of interobserver agreement between MEDIC and SMWI. ROC curve analyses were
conducted to test if there is any significant difference between the reviewers.
Results
Compared to MEDIC, SMWI showed more conspicuous borders of
the substantia nigra and nigrosome 1 regions (Fig. 1), and helped to determine
if there was abnormality in the presumed nigrosome 1 regions (Fig. 2, 3). The MEDIC
imaging had the generalized kappa of 0.989 (CI, 0.896-1.082), whereas SMWI
showed a higher kappa value of 1.339 (CI, 1.232-1.446) without an overlap of
CIs, suggesting significant improvement of interobserver agreement. In the MEDIC
imaging, the AUCs of R3 and R4 were 0.741 and 0.692, respectively, whereas
those of R1 and R2 were 0.870 and 0.826, respectively. The ROC curve analyses
showed significant difference between the experienced and less experienced
reviewers (
P = 0.0138 between R1 and
R3,
P = 0.0031 between R1 and R4,
P = 0.0211 between R2 and R4). In SMWI,
the AUCs of R3 and R4 increased to 0.894 and 0.894, respectively. Both R1 and
R2 also showed higher AUCs (0.933 and 0.933, respectively). There was no
significant difference among the all reviewers in SMWI (
P > 0.05).
Discussion
Here we demonstrated that the SMWI
improved the diagnostic utility of the nigrosome 1 imaging at 3T by increasing
interobserver agreement between the experienced and less-experienced reviewers
and by enhancing diagnostic performance. In previous nigrosome 1 imaging
studies at 3T, various imaging techniques, including PRESTO,
3 SWAN,
4
and MEDIC
5,6 have been applied. All these methods are proprietary
and had relatively limited SNR and CNR. Thus, it is desirable to standardize an imaging technique for
visualization of nigrosome 1. Although MEDIC had higher SNR, it exhibited
relatively low susceptibility weighting, limiting its diagnostic sensitivity
for the nigrosome 1 imaging. On the other hand, SMWI provided high quality
images with good contrast and SNR. SMWI could also enable us to measure
susceptibility values in the substantia nigra by using the QSM map, thereby quantifying
the level of degeneration.
Acknowledgements
No acknowledgement found.References
1. Gho SM, Liu C, Li W, et al. Susceptibility map-weighted imaging (SMWI) for neuroimaging. MRM 2014;72:337-346. 2. Li W, Wang N, Yu F, et al. A method for estimating and removing streaking artifacts in quantitative susceptibility mapping. Neuroimage
2014;108:111-122. 3. Schwarz ST, Afzal M, Morgan PS, et al. The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T. PloS One 2014;9:e93814. 4. Cosottini M, Frosini D, Pesaresi I, et
al. Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease. AJNR Am J Neuroradiol 2015;36:461-466. 5. Noh Y, Sung YH, Lee J, et al. Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality. AJNR Am J Neuroradiol
2015 Aug 20. [Epub ahead of print] 6. Sung YH, Noh Y, Lee J, et al.
Drug-induced Parkinsonism versus Idiopathic
Parkinson’s Disease: Utility of Nigrosome 1 Imaging at 3T. Radiology 2015 in press.